Three distinct failure modes explain the historical record of oral peptide and protein failure: (1) Exposure infeasibility: A short elimination half-life prevents accumulation to a therapeutic body burden at low oral bioavailability, regardless of how sophisticated the formulation technology
GLP-1 meds help people lose significant amounts of weight, reduce their risk of heart disease, stroke, type 2 diabetes, and countless other obesity-related conditions, and in many cases, even reverse metabolic dysfunction
M.DorgauB.MearnsS.BauerR.Al-AamaJ.et al (2021)
successfully detected oligonucleotides up to 150 bases in length using 3-HPA as a matrix, showing that it is superior to DHB or FA for analyzing poly-A, poly-G, poly-C, and mixed-type oligonucleotides
Tack J, Arts J, Caenepeel P, et al
As weve seen in the cost breakdowns above, there is a price cap for what youll pay each month for Nevolat, due to a lower ceiling on dose increases